Vitalstim吞咽障碍治疗仪早期介入手足口病合并吞咽功能障碍疗效分析.docVIP

Vitalstim吞咽障碍治疗仪早期介入手足口病合并吞咽功能障碍疗效分析 　　[摘要] 目的 探讨Vitalstim吞咽治疗仪早期介入手足口病合并吞咽功能障碍的疗效。方法 将60例患者随机分为治疗组和对照组，均给予常规康复治疗，治疗组加用Vitalstim吞咽治疗仪。治疗前后采用洼田饮水试验进行吞咽功能评估。结果 治疗后两组患者的洼田饮水试验评分均有降低，治疗组降低更明显，且治疗组的有效率明显高于对照组，差异有统计学意义（P0.05）。结论 Vitalstim吞咽治疗仪结合常规康复治疗可明显提高手足口病合并吞咽功能障碍患者的吞咽功能。 　　[关键词] 吞咽治疗仪；吞咽功能障碍；手足口病 　　[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2015）04（c）-0011-02 　　[Abstract] Objective To explore the Vitalstim swallowing early therapeutic intervention， foot and mouth disease combined curative effect of swallowing dysfunction. Methods 60 cases of hand， foot and mouth disease were randomly divided into treatment group and control group， both of them were given routine rehabilitation therapy， the treatment group used Vitalstim swallowing therapy apparatus. Before and after treatment to evaluate swallowing function kubota drinking water test. Results The two groups after treatment in patients with kubota drinking water test scores were decreased， the treatment group decreased more obviously， and the efficiency of treatment group was obviously higher than that of control group， the difference was statistically significant（P 0.05）. Conclusion Vitalstim swallowing therapeutic apparatus in combination with conventional rehabilitation treatment can obviously improve the hand， foot and mouth disease merging swallowing function in patients with swallowing dysfunction. 　　[Key words] Swallowing therapeutic apparatus； Swallowing dysfunction； Hand， foot and mouth disease 　　手足口病（Hand，foot and mouth disease，HFMD）是由多种肠道病毒引起的常见传染病[1]。其中重症手足口病伴吞咽功能障碍是其中一种较严重的并发症，可造成脱水、吸人性肺炎、营养不良、窒息等，增加患者的死亡风险。为探讨Vitalstim吞咽治疗仪早期介入手足口病合并吞咽功能障碍的疗效，该院2012年1月―2014 年5月间应用Vitalstim吞咽治疗仪配合常规康复治疗，在治疗该类患儿中取得了较好的效果，现报道如下。 　　1 资料与方法 　　1.1 一般资料 　　随机选取在郑州市儿童医院手足口病监护室及康复科住院的重症手足口病合并吞咽功能障碍的患者60例。随机分为治疗组和对照组。入选标准：①病情稳定（一般从病程的7～14 d开始），均伴有严重的饮水呛咳，康复前需要鼻饲喂养。②年龄1.10～4.8 岁。排除标准：①需要呼吸机。②疾病急性期，伴有癫痫、腭裂等其它并发症。治疗组男18例，女12例，年龄（2.5±1.0）岁，洼田饮水试验评分（4.50 ±0.13）分。对照组男17例，女13例，年龄（2.6±1.2）岁，洼田饮水试验评分（4.56 ±0.25）分。 　　1.2 治疗方法 　　两组患者均